Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 5
2005 2
2006 4
2007 3
2008 7
2009 10
2010 13
2011 11
2012 7
2013 11
2014 5
2015 10
2016 9
2017 9
2018 6
2019 7
2020 8
2021 11
2022 16
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
Fenaux P, Platzbecker U, Mufti GJ, Garcia-Manero G, Buckstein R, Santini V, Díez-Campelo M, Finelli C, Cazzola M, Ilhan O, Sekeres MA, Falantes JF, Arrizabalaga B, Salvi F, Giai V, Vyas P, Bowen D, Selleslag D, DeZern AE, Jurcic JG, Germing U, Götze KS, Quesnel B, Beyne-Rauzy O, Cluzeau T, Voso MT, Mazure D, Vellenga E, Greenberg PL, Hellström-Lindberg E, Zeidan AM, Adès L, Verma A, Savona MR, Laadem A, Benzohra A, Zhang J, Rampersad A, Dunshee DR, Linde PG, Sherman ML, Komrokji RS, List AF. Fenaux P, et al. Among authors: quesnel b. N Engl J Med. 2020 Jan 9;382(2):140-151. doi: 10.1056/NEJMoa1908892. N Engl J Med. 2020. PMID: 31914241 Free article. Clinical Trial.
TRPC3 shapes the ER-mitochondria Ca2+ transfer characterizing tumour-promoting senescence.
Farfariello V, Gordienko DV, Mesilmany L, Touil Y, Germain E, Fliniaux I, Desruelles E, Gkika D, Roudbaraki M, Shapovalov G, Noyer L, Lebas M, Allart L, Zienthal-Gelus N, Iamshanova O, Bonardi F, Figeac M, Laine W, Kluza J, Marchetti P, Quesnel B, Metzger D, Bernard D, Parys JB, Lemonnier L, Prevarskaya N. Farfariello V, et al. Among authors: quesnel b. Nat Commun. 2022 Feb 17;13(1):956. doi: 10.1038/s41467-022-28597-x. Nat Commun. 2022. PMID: 35177596 Free PMC article.
IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein.
Gaggero S, Martinez-Fabregas J, Cozzani A, Fyfe PK, Leprohon M, Yang J, Thomasen FE, Winkelmann H, Magnez R, Conti AG, Wilmes S, Pohler E, van Gijsel Bonnello M, Thuru X, Quesnel B, Soncin F, Piehler J, Lindorff-Larsen K, Roychoudhuri R, Moraga I, Mitra S. Gaggero S, et al. Among authors: quesnel b. Sci Immunol. 2022 Dec 9;7(78):eade5686. doi: 10.1126/sciimmunol.ade5686. Epub 2022 Dec 2. Sci Immunol. 2022. PMID: 36459543
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.
Selimoglu-Buet D, Wagner-Ballon O, Saada V, Bardet V, Itzykson R, Bencheikh L, Morabito M, Met E, Debord C, Benayoun E, Nloga AM, Fenaux P, Braun T, Willekens C, Quesnel B, Adès L, Fontenay M, Rameau P, Droin N, Koscielny S, Solary E; Francophone Myelodysplasia Group. Selimoglu-Buet D, et al. Among authors: quesnel b. Blood. 2015 Jun 4;125(23):3618-26. doi: 10.1182/blood-2015-01-620781. Epub 2015 Apr 7. Blood. 2015. PMID: 25852055 Free PMC article. Clinical Trial.
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mufti G, Mittelman M, Muus P, Te Boekhorst P, Sanz G, Del Cañizo C, Guerci-Bresler A, Nilsson L, Platzbecker U, Lübbert M, Quesnel B, Cazzola M, Ganser A, Bowen D, Schlegelberger B, Aul C, Knight R, Francis J, Fu T, Hellström-Lindberg E; MDS-004 Lenalidomide del5q Study Group. Fenaux P, et al. Among authors: quesnel b. Blood. 2011 Oct 6;118(14):3765-76. doi: 10.1182/blood-2011-01-330126. Epub 2011 Jul 13. Blood. 2011. PMID: 21753188 Free article. Clinical Trial.
CAR T-cells: A John von Neumann legacy?
Quesnel B. Quesnel B. Curr Res Transl Med. 2018 May;66(2):35-36. doi: 10.1016/j.retram.2018.04.002. Epub 2018 Apr 21. Curr Res Transl Med. 2018. PMID: 29685844 No abstract available.
Put in a "Ca2+ll" to Acute Myeloid Leukemia.
Lewuillon C, Laguillaumie MO, Quesnel B, Idziorek T, Touil Y, Lemonnier L. Lewuillon C, et al. Among authors: quesnel b. Cells. 2022 Feb 4;11(3):543. doi: 10.3390/cells11030543. Cells. 2022. PMID: 35159351 Free PMC article. Review.
Acute Myeloid Leukemia: Is It T Time?
Ben Khoud M, Ingegnere T, Quesnel B, Mitra S, Brinster C. Ben Khoud M, et al. Among authors: quesnel b. Cancers (Basel). 2021 May 14;13(10):2385. doi: 10.3390/cancers13102385. Cancers (Basel). 2021. PMID: 34069204 Free PMC article. Review.
Tumor dormancy and immunoescape.
Quesnel B. Quesnel B. APMIS. 2008 Jul-Aug;116(7-8):685-94. doi: 10.1111/j.1600-0463.2008.01163.x. APMIS. 2008. PMID: 18834412 Review.
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma.
Jovanović KK, Escure G, Demonchy J, Willaume A, Van de Wyngaert Z, Farhat M, Chauvet P, Facon T, Quesnel B, Manier S. Jovanović KK, et al. Among authors: quesnel b. Front Oncol. 2019 Jan 9;8:665. doi: 10.3389/fonc.2018.00665. eCollection 2018. Front Oncol. 2019. PMID: 30687640 Free PMC article. Review.
145 results